Ovid Therapeutics Inc. (OVID)

NASDAQ

$2.36

$+0.18

(+8.29%)

After-Hours

Ovid Therapeutics Inc. (OVID) Live Price Chart

Last updated: ⁦2026-10-20 22:03:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Ovid Therapeutics Inc. (OVID) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.36, with a market capitalization of $419.89M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.18 to $3.11. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$419.89M
Open	$2.19
Day's High	$15.93
Day's Low	$0.24
Previous Close	$2.17
Volume	3.50M
Average Volume	1.59M
P/E Ratio	--
52-Week High	$3.11
52-Week Low	$1.18
Dividend Yield	--
Earnings Date	--

Ovid Therapeutics Inc. (OVID) After-Hours Stock Price

Ovid Therapeutics Inc. (OVID) is trading at $2.39 in after-hours trading as of 2026-10-20 21:27:00, up 10.14% ($0.22) from the regular-session close of $2.17.

After-hours trading shows how investors are pricing OVID after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

Ovid Therapeutics Inc. (OVID) 7-Day Stock Price Change

Over the past seven days, Ovid Therapeutics Inc. (OVID) moved from $2.46 to $2.36, representing a decline of 4.27% ($0.10).

The stock traded between $2.09 and $2.49 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 1.41 million shares, down versus the previous seven-day period, indicating lower trading activity.

OVID 52-Week Price Position

Position in Range: 61.0%

52W Low$1.18

52W High$3.11

OVID is currently trading at $2.36, placing it 61.0% of the way from its 52-week low of $1.18 to its 52-week high of $3.11. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Ovid Therapeutics Inc. (OVID)?

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Ovid Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	23
Exchange	NASDAQ
Company Website	https://www.ovidrx.com

How to Buy Ovid Therapeutics Inc. (OVID) Stock on MEXC

Eligible investors can buy real shares of Ovid Therapeutics Inc. (OVID) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for OVID and Place Your Order

Open the RealStocks trading page and search for OVID. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Ovid Therapeutics Inc. (OVID) stock price today?

Ovid Therapeutics Inc. (OVID) is currently trading at $ 2.36, up 8.53% ($0.19) from the previous close of $ 2.17. Intraday prices update in real time during regular trading hours.

2.Is OVID stock going up or down today?

As of 2026-10-20 21:27:00, OVID is trading at $ 2.36, up 8.53% ($0.19) from its previous close of $ 2.17. The stock has traded between $ 0.24 and $ 15.93 during today’s regular session. Past price movements do not guarantee future results.

3.What is OVID pre-market price?

As of 2026-10-20 21:27:00, OVID is trading at $ 2.30 in pre-market trading, up 5.90% ($0.13) from the previous close of $ 2.17. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is OVID after-hours price?

As of 2026-10-20 21:27:00, OVID is trading at $ 2.39 in after-hours trading, up 10.14% ($0.22) from the regular-session close of $ 2.17. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is OVID stock trading now?

OVID trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does OVID sit relative to its 52-week high and low?

Over the past 52 weeks, OVID has traded between a low of $ 1.18 and a high of $ 3.11. At $ 2.36, the stock is positioned 61.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Ovid Therapeutics Inc. in?

Ovid Therapeutics Inc. (OVID) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Ovid Therapeutics Inc.'s market capitalization and where is it listed?

Ovid Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 419.89M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is OVID valued in terms of P/E ratio and EPS?

OVID trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.18. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Ovid Therapeutics Inc. pay a dividend?

Ovid Therapeutics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.